首页> 外文期刊>The international journal of artificial organs >Use of octreotide to treat prolonged sulfonylurea-induced hypoglycemia in a patient with chronic renal failure.
【24h】

Use of octreotide to treat prolonged sulfonylurea-induced hypoglycemia in a patient with chronic renal failure.

机译:奥曲肽用于治疗慢性肾功能衰竭患者长期磺酰脲引起的低血糖症。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

A diabetic patient with chronic renal failure who developed recurrent and prolonged episodes of hypoglycemia associated with use of sulfonylurea agent is presented here. This patient was hospitalized with neuroglycopenic symptoms of hypoglycemia that persisted in spite of large doses of parenteral glucose replacement. On administration of somatostatin analogue octreotide, hypoglycemia resolved and, blood glucose levels were maintained even after cessation of parenteral glucose. The patient received 2 subcutaneous doses of octreotide 12 hours apart, and made a complete recovery. Our experience suggests that use of octerotide to treat refractory or prolonged sulfonylurea-included hypoglycemia in renal failure patients is safe and effective; large prospective studies would be needed to validate these findings.
机译:本文介绍了一名患有慢性肾功能衰竭的糖尿病患者,该患者出现反复和长期出现的与使用磺酰脲类药物相关的低血糖事件。该患者因低血糖的神经血糖症状而住院治疗,尽管大剂量肠胃外葡萄糖替代治疗仍持续存在。服用生长抑素类似物奥曲肽后,低血糖症得以缓解,即使停用肠胃外葡萄糖,血糖水平也得以维持。该患者相隔12小时接受2剂皮下注射奥曲肽,并完全康复。我们的经验表明,在肾衰竭患者中使用奥曲肽治疗难治性或长期性磺酰脲类低血糖症是安全有效的。需要大量的前瞻性研究来验证这些发现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号